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Ingesting melamine adulterated milk products led to kidney stones in many infants in 2008. This differs
from the renal failure caused by intratubular crystal formation after co-ingestion of melamine (MEL) and
cyanuric acid (CYA) in adulterated pet foods in 2007. To better understand the potential risk of developing
crystal nephropathy following co-ingestion of MEL and CYA, we fed 16 weanling pigs 0, 1, 3.3, 10, 33, or
100 mg/kg bw/day of eachMEL and CYA, or 200 mg/kg bw/day of either compound individually for 7 days.
Crystals were found in the renal medulla and cortex and urine sediments of all pigs fed both MEL and CYA
each at 10 mg/kg bw/day (or greater). Crystalswere also found in one of the twopigs fed 200 mg/kg bw/day
MEL-only. In a 28 day study, 36weanling pigswere fed 0, 1, or 3.3 mg/kg bw/dayofMEL andCYAor 200 mg/
kg bw/day MEL-only. Only one of the 3.3 mg/kg MEL and CYA pig kidneys contained crystals. The
no-observed-adverse-effect level (NOAEL) for pigs fed MEL and CYA for 28 days was concluded to be
1.0 mg/kg bw/day corresponding to 25 mg/kg (ppm) MEL and 25 mg/kg (ppm) CYA in dry feed.
Published by Elsevier Inc.Open access under CC BY-NC-ND license.1. Introduction Retrospective studies have found that episodes of melamine re-In 2007, melamine and a mixture of other triazines including
cyanuric acid were intentionally added to food commodities such
as wheat gluten and rice protein concentrate to boost apparent
protein content. When those ingredients were used to make pet
food, many cats and dogs in the US, Canada and South Africa devel-
oped kidney failure due to formation of melamine–cyanurate crys-
talline spherulites in renal tubules (Brown et al., 2007; Cianciolo
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C BY-NC-ND license.lated renal failure (MARF) had occurred previously in Korea, Spain
and Thailand but had not been clearly characterized before 2007
(González et al., 2009; Nilubol et al., 2009; Yhee et al., 2009). While
melamine and cyanuric acid have a variety of industrial and
agricultural uses, neither is an approved additive for human or
animal foodstuffs.
Animals destined for human consumption were also exposed to
contaminated feed. Adulterated wheat gluten and pet food byprod-
ucts contaminated with melamine and related triazines had been
used in feeds for hogs, chicken and ﬁsh. As a result, 56,000 hogs
were placed under quarantine in seven states (USDA, 2007a). These
animals were later released for slaughter and human consumption
once samples of pork were found to have residue levels of less than
0.05 mg/kg (50 ppb) wet weight melamine, and unlikely to be a
human health risk (USDA, 2007b). Subsequent modeling studies
based on serum values indicate a withdrawal time for pigs exposed
to melamine would likely be less than one day (Buur et al., 2008).
Further, melamine’s half life in pigs is 4.04 h and therefore resi-
dence time in tissues was considered insigniﬁcant (Baynes et al.,
2008). However neither of these studies investigated the toxicity
or persistence of residues following co-ingestion of melamine
and cyanuric acid and risk assessments at that time concentrated
on exposure to MEL alone (USFDA, 2007).
As the pet food contamination investigations continued, in 2008
hundreds of thousands of Chinese children were affected by
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six children due to renal failure (WHO, 2008). The median level
of melamine in infant formula raw materials was 188,000 mg/
kg dry weight, whereas comparably trace amounts of cyanuric acid
(3.2 mg/kg), ammeline (14.9 mg/kg) and ammelide (293 mg/kg)
were detected (WHO, 2008; Wu et al., 2009). The range of mela-
mine concentrations in infant formula samples was <0.05–
4700 mg/kg dry weight (WHO, 2008; Wu et al., 2009). In contrast
to the intra tubular melamine–cyanuric acid crystals seen in pets,
much larger urinary tract stones composed of melamine and uric
acid had formed in approximately 300,000 children who drank
contaminated infant formula (Sun et al., 2008; Guan et al., 2009;
Kuehn, 2009; Shen et al., 2009). In response to this public health
crisis, health organizations around the world conducted risk
assessments to evaluate risk to consumers, again, focusing on
exposure to MEL alone (Anon, 2008; AQSIQ, 2008; Centre for Food
Safety, Hong Kong, 2008; Commission of the European Communi-
ties, 2008; New Zealand Food Safety Authority, 2008; USFDA,
2008a,b).
Until the events of 2007 and 2008, both MEL and CYA were con-
sidered relatively non-toxic compounds. The LD50 for rats has
been reported to be 3161 mg/kg bw for MEL and >5000 mg/kg bw
for CYA (IUCLID, 2000a,b). Stones and urinary tract epithelial
hyperplasia or neoplasms were reported in rats chronically ex-
posed to melamine for 2 years (Ogasawara et al., 1995; Melnick
et al., 1984; NTP, 1983). Further, micro-crystals were reported on
gross post mortem but no histopathologic lesions were described
(Ogasawara et al., 1995). The combined toxicity of MEL- and
CYA-only became apparent in 2007 when pets developed renal
failure due to the intratubular precipitation of melamine–
cyanurate crystals. Subsequent experimental models in which mel-
amine and cyanuric acid were fed at a ratio of 1:1 have clearly
demonstrated that ingestion of these compounds together causes
crystal formation and subsequent renal failure in cats, ﬁsh, pigs
and rats (Reimschuessel et al., 2008; Puschner et al., 2007; Chen
et al., 2009; Dobson et al., 2008; Kim et al., 2010; Kobayashi
et al., 2010; Xie et al., 2010). It is important to note, however, that
whereas the pet food adulteration was in close to a 1:1 MEL:CYA
ratio, and the milk products were adulterated with almost pure
MEL, these were not always the triazine adulterants nor ratios seen
in the past, and there is no guarantee that these will be the triazine
compounds nor ratios of adulterants in the future (González et al.,
2009; Nilubol et al., 2009; Yhee et al., 2009).
During these incidents and risk assessments, knowledge gaps
were identiﬁed, speciﬁcally the lack of dose response data for com-
bined MEL and CYA ingestion. At the time, the USFDA’s Center for
Veterinary Medicine (CVM) was in the process of conducting a No
Observable Adverse Effects Level (NOAEL) study on MEL and CYA
combined using ﬁsh as a non-mammalian model. The 28-day
NOAEL, at which no renal crystals were observed for catﬁsh or
trout, was 0.5 mg/kg bw/day of each compound (Reimschuessel
et al., 2010). The data from ﬁsh represents a worst case scenario
since ﬁsh excrete compounds more slowly than mammals (Reim-
schuessel et al., 2005). In an effort to more closely model human
risks, FDA deemed that NOAEL studies were warranted using a
mammalian species. Two species were chosen, rats which are fre-
quently used as a toxicological model, and pigs. The porcine model
was chosen as pigs have an anatomically similar kidney to that of
humans, and have traditionally been used in urologic research,
including increased intrarenal pressure and ureteral obstructive
studies (Sampaio et al., 1998; Dalmose et al., 2000; Rawashdeh
et al., 2003; Dissing et al., 2008). The study using rats was con-
ducted by the National Center for Toxicological Research (NCTR)
(Jacob et al., 2011) and the pig study was conducted by Center
for Veterinary Medicine (CVM). The dosages for both studies were
harmonized to maximize the comparative value of those studies.Further, as the milk products adulterated with melamine in China
in 2008 were relatively free of other triazines including cyanuric
acid, and produced melamine–uric acid stones in children and in-
fants, the FDA was also interested in investigating the pathology
resulting from exposure to each compound alone.
The key parameter evaluated in this study was crystal forma-
tion observed by examining fresh renal tissue (wet mount sec-
tions). Crystal presence in kidneys has been shown to be a more
sensitive indicator of effect than routine histopathology or clinical
hematology such as blood urea nitrogen (BUN) and creatinine.
Crystals have been seen in kidneys of rats given combined MEL
and CYA at dosages where the BUN and creatinine remain normal
(Jacob et al., 2011). Herein we report the results of a pilot 7 day
study and a 28 day exposure study to determine the NOAEL for
crystal formation in weanling pigs following co-ingestion of mela-
mine and cyanuric acid, and also to investigate the crystal forma-
tion potential of pigs dosed with each compound alone.2. Methods
2.1. Animals, husbandry and test articles
2.1.1. Seven day range ﬁnding study
Weanling cross-bred barrows (n = 16, 23 ± 3 kg bw) were ob-
tained from a local producer. Ear-tagged pigs were housed in indi-
vidual indoor pens at the USFDA’s Center for Veterinary Medicine,
Ofﬁce of Research in Laurel, MD and acclimated for at least
2 weeks. A standard health check was performed by the attending
veterinarian upon the pigs’ arrival to our facility. Pigs were fed a
standard corn and soybean diet (18% crude protein) prepared at
our facility and had unrestricted access to fresh water. All feeds,
including those from the local producer, were tested for the pres-
ence of MEL and CYA by liquid chromatography tandemmass spec-
trometry and no peaks were detected above the limit of
quantiﬁcation, 0.5 mg/kg dry weight (Heller and Nochetto, 2008).
Pigs were weighed daily and were observed twice daily for signs
of distress or other health issues.
2.1.2. Twenty eight day study
Weanling pigs (n = 36, 24 ± 2 kg bw) were also obtained from
local farms and housed as stated above for the pilot study.
2.1.3. Test articles
Melamine (MEL; 99% pure; Sigma–Aldrich Co., St. Louis, MO,
USA) and/or cyanuric acid (CYA; 98% pure; Sigma–Aldrich Co., St.
Louis, MO, USA) were mixed with retail chocolate pudding in
amounts tabulated from daily weight measurements to ensure
accurate dosing. Pudding also tested negative for melamine and
cyanuric acid. All pigs ate all pudding each dosing day and thus re-
ceived complete test doses.
2.2. Experimental design
2.2.1. Seven day range ﬁnding study
In the 7 day study, pigs were randomly assigned to treatment
groups of 0, 1.0, 3.3, 10, 33, or 100 mg/kg bw/day of melamine
and cyanuric acid each (MEL + CYA) or 200 mg/kg bw/day of either
compound individually (MEL or CYA; n = 2 each treatment). The
notation used in this report is that a dosage of 100 MEL + CYA indi-
cates 100 mg/kg bw/day of MEL and 100 mg/kg bw/day of CYA
were fed for a total of 200 mg/kg bw/day of triazines. MEL and
CYA were given in a ratio of 1:1 as this was the ratio that had been
shown to cause crystals in pigs, ﬁsh, cats and rats in previous stud-
ies and the doses were chosen to harmonize results with a rat
study at the National Center for Toxicological Research (Puschner
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et al., 2011). Pigs were given the test compound(s) in the morning
(approximately 23–25 h apart) for 7 consecutive days and euthan-
atized on the 8th day.
2.2.2. Twenty eight day study
In the 28 day study, 24 pigs were randomly assigned to 3 dosage
groups, 0, 1.0, or 3.3 mg/kg bw/day of MEL + CYA (n = 8 per group).
Due to space limitations, two trials were run, each with half the
animals. Controls were split between the two trials. A third trial
was added later to examine the effects of MEL-only administration.
This was done because crystals were found in one of the MEL-only
pigs during the 7 day study and because the infant formula in Chi-
na was adulterated with essentially pure MEL. Therefore, the third
trial used 8 MEL-only pigs (200 mg/kg bw/day MEL) and 4 addi-
tional control pigs. The numbers of animals was based on both
the need to provide preliminary risk assessment data but also on
the need to adhere to IACUC guidelines for reducing the number
of large mammals used in research. Pigs were given the test com-
pound(s) in the morning (approximately 23–25 h apart) for 28 con-
secutive days and euthanatized on the 29th day.
2.3. Necropsy
2.3.1. Necropsy and pathological evaluations
Final pig weights were recorded live. Twenty-four hours follow-
ing the ﬁnal dose, pigs were euthanatized by a penetrating captive
bolt followed by exsanguination, at which time whole blood was
collected. Anesthesia was not used so that tissue samples would
be free of anesthetic drug residues. Gross necropsy included visual
examination for any external or internal lesions (including kidney
cysts, soft masses and cartilage pathology). If any lesions were
present they were recorded and samples were ﬁxed in 10% neutral
buffered formalin (NBF) for routine histopathology.
Kidneyswere excisedwhole andweighed. One kidneywas cut in
half sagitally and thin slices of medulla and cortex were taken for
wet mount observation of typical melamine–cyanurate spherulite
crystals. Fresh tissuewasplacedon amicroscope slide, overlaidwith
a cover slip, and compressed with another slide (Reimschuessel
et al., 2008). The slides were observed on an inverted microscope
and ranked on a subjective scale from 0 to 5 as follows: 0 – no crys-
tals seen; 1 – only 1 crystal in an entire section; 2 – few crystalswith
scattered distribution; 3 – moderate numbers of crystals seen
throughout section; 4 – large numbers of crystals seen immediately;
and 5 – extensive numbers of crystals obliterating the regular tissue
architecture. Medulla and cortex samples were also preserved in
10% NBF, 70% ethanol, as well as frozen at 80 C for archival pur-
poses. All NBF samples were processed for routine histology.
The bladder was excised and total urine was taken by emptying
the bladder into a bottle. A microscope slide was scraped along the
fundus and observed under at least 20magniﬁcation for crystals.
Portions of the bladder were ﬁxed in NBF and 70% ethanol. The ure-
thra was removed and palpated for the presence of stones. Samples
of the urethra were also ﬁxed in 10% NBF. As previous studies in
ﬁsh showed intestinal tract crystals (Reimschuessel et al., 2008),
portions of stomach, duodenum, jejunum, and ileum, were taken
and ﬁxed in 10% NBF. The ureter and penis were examined in sev-
eral animals. Routine samples were limited to the urogenital and
gastrointestinal tracts as previous laboratory studies have shown
these tissues to be the target organs in MEL and CYA toxicity and
this study was designed to focus on the adverse effect on which
to base the NOAEL (Dobson et al., 2008; Puschner et al., 2007).
Approximately 1 kg each of ham (consisting of semitendinosus,
semimembranosus, and biceps femoris muscles) and loin (longiss-
imus lumborum), as well as the whole liver and the whole second
kidney, were cubed and stored at 10 C for archival purposes.2.3.2. Serum chemistry and urine evaluations
Whole blood samples were allowed to clot and were centri-
fuged for 15 min. Serum was removed and stored at 20 C until
analyses. Serum was processed on a VetTest™ Chemistry Analyzer
(IDEXX Laboratories, Inc., Westbrook, ME, USA) to evaluate renal
function factors BUN and creatinine. Statistical comparisons were
made by Kruskal–Wallis one way Analysis of Variance (ANOVA)
on ranks since the data failed normality or equal variance tests
(SigmaStat v.3.5, Aspire Software International, Ashburn, VA).
Total urine was tested for glucose, bilirubin, ketones, speciﬁc
gravity, traces of blood, pH, proteins, urobilinogen, nitrite and leu-
kocytes with Siemens Multistix 10 SG (Bayer HealthCare LLC, Elk-
hart, IN, USA). A 15 mL subsample of total urine collections were
centrifuged for 5 min and sediments were removed and evaluated
microscopically for the detection of crystals.
This study followed Good Laboratory Practices (GLP) and proto-
cols were approved by the USFDA CVM Institutional Animal Care
and Use Committee (IACUC).
2.4. Analysis of crystals from 200 MEL-only pig
Approximately 2 mm thick defrosted kidney sections were
placed over waxed paper under an invertedmicroscope (magniﬁca-
tion 30X) and crystals were collected using 18 1½ G needles. The
bevel of the needles was used to section the tissue and remove
the crystals along with as little tissue as possible. The crystal sam-
ples were deposited into 0.5 mL microcentrifuge tubes containing
100 lL of 10 mM pH 5.0 sodium phosphate buffer. Approximately
ﬁve crystals were collected into each of two tubes per kidney sam-
ple. The tubes were vortexed strongly, sonicated in a water bath for
2 min, and centrifuged at 21,000g for 5 min. The supernatant was
carefully transferred into total recovery autosampler vials (Waters
Corporation, Milford, MA). The samples were analyzed by UPLC-
MS/MS using a Waters Acquity UPLC system interfaced with a
Waters Quattro Premier XE tandem mass spectrometer equipped
with an electrospray ionization source. The samples (2 lL) were
eluted isocratically at 450 lL/min with 5% of 10 mM ammonium
acetate and 95% acetonitrile using a ZIC-HILIC column (150 
2.1 mm, 3.5 lm, 100 Å, SeQuant, Umeå, Sweden) set at 35 C. The
mass spectral analyses were conducted by multiple reaction moni-
toring (MRM), switching between positive (for melamine) and neg-
ative electrospray mode (for cyanuric acid). The monitored
transitions for an argon collision cell pressure of 1.3 mTorr were
as follows: m/z 127.8? 42.3 at 12 eV (cyanuric acid primary tran-
sition), m/z 127.8? 85.1 at 10 eV (cyanuric acid secondary transi-
tion), m/z 126.9? 85.00 at 18 eV (melamine primary transition),
and m/z 126.9? 68.15 at 23 eV (melamine secondary transition).
These analyses were conducted by a collaborating lab following
standard laboratory procedures.
2.5. Determination of Benchmark dose (BMD) modeling
Benchmark doses (BMD) and the lower (BMDL) 95% conﬁdence
limits were calculated using Environmental Protection Agency
Benchmark Dose Software (version 2.1.2; http://www.epa.gov/
ncea/bmds/). The calculations were conducted using logistic and
probit models for Dichotomous (Quantal) data.3. Results
3.1. Morphometrics
3.1.1. Seven day range ﬁnding study
In the 7 day range ﬁnding study, starting pig weights ranged
from 19.2–27.2 kg and ending weights ranged from 22.2 to
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had lower weight gains (2.6 and 1.0 kg gains) over the study period
than the controls (3.4 and 4.0 kg). The MEL-only (4.0, 4.0 kg) and
CYA-only (3.2, 4.0 kg) pigs’ weight gain was comparable to the con-
trols’ weight gain. The weight gains of the other MEL + CYA groups
were also comparable to the controls’.
The average kidney weight/ﬁnal body weights of the pigs given
100 MEL + CYA were higher than those of the other groups (Table
1). Both average kidney weight and average kidney weight/ﬁnal
body weight appear to have a dose response above 10 MEL + CYA
(Fig. 1).3.1.2. Twenty eight day main study
In the 28 day study, pigs entered the experimental period at
19.2–28.0 kg and were 35.0–49.0 kg at necropsy. The percent body
weight gain over the course of the study of all experimental groups
(15.8–21.8 kg) was comparable to that of the controls (15.0–
21.0 kg).Table 1
Morphometrics, serum chemistry and ranking of renal crystals in wet mount from weanlin
ranking was from 0 to 5 as follows: 0 – no crystals seen; 1 – only 1 crystal in an entire sectio
throughout section; 4 – large numbers of crystals seen immediately; and 5 – extensive num
weight divided by ﬁnal weight was elevated in pigs receiving 100 MEL + CYA. BUN was ele
only in those pigs receiving 100 MEL + CYA. bw, body weight; BUN, blood urea nitrogen;
Dose (mg
/kg bw/day)
Initial
weight (kg)
Body weight
gain (%)
Average kidney
weight (g)
Average kid
weight/ﬁna
bw (g/kg)
0 20 17 47 2
0 24 17 63 2
1 M + C 27 17 81 3
1 M + C 19 16 51 2
3.3 M + C 25 18 68 2
3.3 M + C 21 12 55 2
10 M + C 25 18 59 2
10 M + C 20 15 51 2
33 M + C 22 13 77 3
33 M + C 27 15 96 3
100 M + C 23 11 160 6
100 M + C 22 4 125 5
200 MEL 20 20 66 3
200 MEL 27 15 74 2
200 CYA 27 15 63 2
200 CYA 22 15 67 3
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Fig. 1. Average kidney weight and average kidney weight corrected for body weight fo
weight as well as the kidney to body weight ratio was higher in the 33 MEL + CYA and 10
variable.Average kidney weights of the dose groups ranged from 71 to
121 g and were not associated with dose (Table 2). Average kidney
weight/body weight remained constant (range 1.72–2.69 g/kg) and
was not associated with dose.
One pig given 200 MEL-only had a 8 cm by 3.5 cm soft mass
over the sternum and the skin was slightly bruised on the anterior
most third. One pig given 3.3 mg/kg bw/day MEL + CYA appeared
to be limping pre-necropsy. The left tibia tarsal bone had a 1 mm
by 5 mm cartilage defect, causing rough edges and thinning on
the trochlear ridge and the distal tibia.3.2. Wet mounts
3.2.1. Seven day range ﬁnding study
In the 7 day study, crystalline spherulites, consistent with the
melamine–cyanurate crystals found during the pet food contami-
nation incident of 2007, were found in the medulla and cortex
wet mounts of the kidneys (Fig. 2 A and B), as well as in the urineg pigs given melamine and/or cyanuric acid for 7 days. The subjective scale for crystal
n; 2 – few crystals with scattered distribution; 3 – moderate numbers of crystals seen
bers of crystals obliterating the regular tissue architecture. The ratio of average kidney
vated in pigs receiving 33 MEL + CYA and 100 MEL + CYA whereas CREA was elevated
CREA, creatinine.
ney
l
BUN
(mg/dl)
CREA
(mg/dl)
pH Crystal rank (0–5)
Medulla Cortex Urine
sediment
14 1.7 6.0 0 0 0
11 1.2 6.0 0 0 0
10 1.3 7.0 0 0 0
12 1.1 6.0 0 0 0
16 1.3 5.0 0 0 0
13 1.3 6.5 0 0 0
14 1.3 6.0 2 1 5
10 1.1 8.0 1 1 3
23 1.4 6.5 5 3 5
15 1.1 5.0 4 3 5
58 7.7 8.0 5 5 5
115 8.9 8.0 4 5 3
15 1.2 6.0 0 0 0
13 1.3 8.0 3 2 3
10 1.6 7.5 0 0 0
7 0.9 8.5 0 0 0
3 M+C 100 M+C 200 MEL 200 CYA
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r weanling pigs given melamine and/or cyanuric acid for 7 days. Absolute kidney
0 MEL + CYA groups. No groups were statistically different from each other in either
Table 2
Morphometrics, serum chemistry and ranking of renal crystals in wet mount from weanling pigs given melamine and cyanuric acid or melamine alone for 28 days. The subjective
scale for crystal ranking was from 0 to 5 as follows: 0 – no crystals seen; 1 – only 1 crystal in an entire section; 2 – few crystals with scattered distribution; 3 – moderate numbers
of crystals seen throughout section; 4 – large numbers of crystals seen immediately; and 5 – extensive numbers of crystals obliterating the regular tissue architecture. All values
of morphometrics and serum chemistry were within normal ranges or did not differ from the controls. As one pig given 3.3 mg/kg bw/day had a crystal in the medulla, the NOAEL
was determined to be 1.0 mg/kg bw/day. bw, body weight; BUN, blood urea nitrogen; CREA, creatinine.
Dose
(mg/kg bw/day)
Initial
weight (kg)
Body weight
gain (%)
Average
kidney
weight (g)
Average kidney
weight/ﬁnal
bw (g/kg)
BUN
(mg/dl)
CREA
(mg/dl)
pH Crystal rank (0–5)
Medulla Cortex Urine sediment
0 23 79 79 2 11 1.0 8.0 0 0 0
0 22 85 84 2 9 1.3 8.0 0 0 0
0 19 88 71 2 12 1.1 8.5 0 0 0
0 20 75 66 2 14 1.4 8.5 0 0 0
0 24 77 75 2 13 1.2 8.5 0 0 0
0 24 86 111 2 6 1.0 8.0 0 0 0
0 24 79 93 2 10 1.2 5.0 0 0 0
0 24 77 98 2 8 0.9 8.0 0 0 0
0 23 80 79 2 11 1.3 6.5 0 0 0
0 25 84 79 2 11 1.1 6.0 0 0 0
0 26 75 98 2 6 1.0 7.5 0 0 0
0 25 79 96 2 12 1.2 6.5 0 0 0
1 M + C 23 79 100 2 5 1.0 8.0 0 0 0
1 M + C 23 77 86 2 14 1.2 6.0 0 0 0
1 M + C 23 76 95 2 11 1.3 8.0 0 0 0
1 M + C 21 79 73 2 14 1.2 8.0 0 0 0
1 M + C 26 77 91 2 12 1.3 6.0 0 0 0
1 M + C 27 73 82 2 10 1.4 6.0 0 0 0
1 M + C 25 84 96 2 9 1.1 8.0 0 0 0
1 M + C 26 84 92 2 15 1.3 7.5 0 0 0
3.3 M + C 21 82 78 2 8 1.0 8.0 0 0 0
3.3 M + C 19 84 89 2 10 1.2 7.5 1 0 0
3.3 M + C 20 78 81 2 9 1.1 8.0 0 0 0
3.3 M + C 21 77 92 2 8 0.9 7.5 0 0 0
3.3 M + C 22 74 71 2 13 1.3 6.5 0 0 0
3.3 M + C 27 77 95 2 10 1.4 6.0 0 0 0
3.3 M + C 26 76 121 3 11 1.1 8.5 0 0 0
3.3 M + C 28 75 85 2 14 1.6 7.0 0 0 0
200 MEL 23 80 86 2 10 1.0 8.5 0 0 0
200 MEL 23 78 80 2 10 1.0 7.5 0 0 0
200 MEL 24 71 94 2 8 1.1 8.5 0 0 0
200 MEL 26 74 88 2 11 1.0 7.0 0 0 0
200 MEL 24 81 91 2 11 1.0 7.5 0 0 0
200 MEL 25 78 90 2 9 1.2 8.0 0 0 0
200 MEL 25 71 89 2 14 1.3 8.0 0 0 0
200 MEL 23 77 90 2 8 1.1 8.0 0 0 0
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at 10, 33, and 100 mg/kg bw/day MEL + CYA levels. Similar crystals
were found in the wet mount and urine sediment of one pig given
200 mg/kg bw/day MEL-only (Fig. 2 C, D, G and H). Crystal rank in
the medulla and cortex decreased as dose decreased (Table 1). The
NOAEL based upon formation of renal crystals after exposure for
7 days was 3.3 mg/kg bw/day.
3.2.2. Twenty eight day main study
In the 28 day main study, no crystals were found in the urine
sediments of any pigs fed at 0, 1.0 or 3.3 mg/kg bw/day of MEL +
CYA or 200 mg/kg bw/day MEL. One of eight pigs given 3.3
mg/kg bw/day of MEL + CYA had a small cluster of crystals with
morphology typical of melamine–cyanurate crystals in the kidney
wet mount (Table 2). The NOAEL based upon formation of renal
crystals after exposure for 28 days was 1 mg/kg bw/day.
3.2.3. Non-typical crystalline structures
Several types of non-typical, clear, crystal-like structures were
seen in pig kidneys in several dose groups. The ﬁrst type of spher-
ical crystals were birefringent, approximately 25 lm in diameter,
had rough margins and several dark striations radiating from the
center typically with the three most prominent in a ‘sand dollar’
conﬁguration, reminiscent of oxalate crystals. A second type were
similar to the ﬁrst however did not contain the striations and were
only mildly birefringent. A third type of abnormal structureconsisted of sausage shaped objects with an outer irregular surface
and no striations or characteristic crystalline features, up to 75 lm
long. These were not birefringent.
3.3. Kidney function
3.3.1. Seven day range ﬁnding study
In the 7 day study, pigs given 100 MEL + CYA had elevated BUN
levels (58 and 115 mg/dl) as did one pig given 33 MEL + CYA
(23 mg/dl) versus control pigs (11 and 14 mg/dl). The 100 MEL +
CYA pigs also had elevated CREA levels (7.7 and 8.9 mg/dl) versus
controls (1.2 and 1.7 mg/dl; Table 1). No comparisons were found
to be statistically signiﬁcant (BUN p = 0.097, CREA p = 0.51).
3.3.2. Twenty eight day main study
BUN and CREA levels were normal for all pigs in the 28 day
study. BUN ranged from 5 to 15 mg/dl and CREA ranged from 0.9
to 1.6 mg/dl (Table 2).
3.4. Urine analysis
In both studies, urine pH ranged from5.0 to 8.5 andwas not asso-
ciated with dose (Tables 1 and 2). Speciﬁc gravity values were nor-
mal and ranged from 1.005 to 1.030. All other parameters on the
test strip (glucose, bilirubin, ketones, blood, protein, urobilinogen,
nitrite and leukocytes)were either negative orwithin normal limits.
Fig. 2. Photomicrographs of the crystal nephropathy in male weanling pigs given melamine and cyanuric acid or melamine only. A wet-mount of crystals in the kidney cortex
from a pig given 100 mg/kg of melamine and cyanuric acid each is shown (A; bar = 500 lm). Higher magniﬁcation (B; bar = 50 lm) shows crystals from A. The melamine–
cyanurate crystals in B can be compared with the crystals in a kidney wet-mount from a pig given 200 mg/kg of melamine only (C; bar = 200 lm), and under higher
magniﬁcation (D; bar = 50 lm). Typical melamine–cyanurate spherulites (B) frequently formed sausage shaped agglomerates within tubules. The crystals from the pig dosed
with only melamine (D) varied in shape including solid cylindrical, fan and branched patterns. The crystal color was similar to that of the typical melamine–cyanurate
crystals. Typical melamine–cyanurate crystals in the urine sediment from a pig given 100 mg/kg of melamine and cyanuric acid each are shown under bright ﬁeld (E) and
polarized light (F; bars = 50 lm). Typical crystals in E and F are more rounded compared with the coral-like shaped crystals (with debris) in the urine sediment from a pig
given 200 mg/kg of melamine only under bright ﬁeld (G) and polarized light (H; bars = 20 lm). Hematoxylin and Eosin sections show melamine–cyanurate crystals in the
renal tubules, from a pig given 100 mg/kg of melamine and cyanuric acid each, shown under bright ﬁeld (I) and polarized light (J; Ethanol ﬁxation; H&E stain; bars = 50 lm).
Crystals were not seen in the H&E slides from any pigs given 200 mg/kg of melamine only.
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3.5.1. Seven day range ﬁnding study
In the 7 day study, typical crystals were observed in the me-
dulla and cortex of all pigs given either 33 MEL + CYA or 100MEL + CYA in the 7 day study. Crystals were shown en section
localized in the tubules of pigs given MEL + CYA (Fig. 2 I and
J) but not in any of the pigs given MEL alone. Further, no crys-
tals were seen en section in pigs with less than a crystal rank
of 4 or 5 in the kidney wet mount (Table 1). No other
Fig. 3. Crystals micro-dissected with an 18 1½ G needle from the kidney of a male
weanling pig given 200 mg/kg bw/day of melamine only. Crystals were found both
in clumps (A) and individually (B). Scale bars = 150 lm.
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other tissues.3.5.2. Twenty eight day main study
In the 28 day study no typical melamine–cyanurate crystals
were observed in any tissues from the pigs. The cartilage sample
taken from the defect in the tibia tarsal bone showed frayed carti-
lage en section most likely related to trauma unrelated to study
parameters. Several kidneys had incidental renal cysts in both con-
trols and experimental animals. Lesions in skin and the leg were
consistent with minor trauma. No other signiﬁcant lesions were
noted in the histologic evaluation of other tissues.3.6. Analysis of crystals from 200 MEL-only pig
Crystals micro-dissected from the kidney of the 200 MEL pig
(Fig. 3) and a pig given 100 MEL + CYA were analyzed by UPLC-
MS/MS. The retention times and primary to secondary transition
ratios of melamine and cyanuric acid in the 600 pg/uL standard
were consistent with those observed in the analyses of the crystal
samples obtained from the combined treatment kidney and theB - 
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Fig. 4. Multiple reaction monitoring chromatograms obtained in the analysis of a 600 p
from a control kidney (panel B), a sample of crystals obtained from the kidney of a pig tre
of crystals obtained from a pig treated with 200 mg/kg bw/day of melamine (panel D). T
primary transition), m/z 127.8? 85.1 at 10 eV (cyanuric acid secondary transition), m/z
23 eV (melamine secondary transition).200 MEL kidney, indicating that both sets of crystals contained
melamine and cyanuric acid (Fig. 4 A, C and D). A control sample,
obtained by simulating the crystal collection in a sample of kidney
from a control animal, failed to reveal any melamine or cyanuric
acid (Fig. 4 B). In order to obtain a semi-quantitative estimate of
the crystal composition, the ratios of the peak integrations of mel-
amine to cyanuric acid were determined in the crystal samples,
and compared to those obtained with the 600 pg/uL standard (cor-
responding to a 1:1 ratio of melamine to cyanuric acid). The ratios
thus obtained were not signiﬁcantly different (<30%) from that of
the standard, suggesting that both sets of crystals were composed
by approximately equal amounts of melamine and cyanuric acid.3.7. Benchmark dose (BMD)
Benchmark doses at 95% conﬁdence for the 7 day pilot study
using the logistic model were BMD = 5.56 mg/kg bw/day, BMDL =
1.52 mg/kg bw/day; and probit model BMD = 5.25 mg/kg bw/day,
BMDL = 1.49 mg/kg bw/day. Benchmark doses at 95% conﬁdence
for the 28 day study using the logistic model were BMD =
3.27 mg/kg bw/day, BMDL = 2.03 mg/kg bw/day; and probit model
were BMD = 3.24 mg/kg bw/day, BMDL = 1.89 mg/kg bw/day.4. Discussion
Following the pet food recall and the infant formula events of
2007 and 2008, risk assessors worldwide struggled to evaluate
and characterize the hazards associated with triazines in human
food and animal feeds. One of the largest hindrances to those ef-
forts was data gaps related to the combined toxicity of melamine
and cyanuric acid. Initial studies focused on documenting crystal
formation and correlating it to the toxicity, often at the high dos-
ages found in the animal feedstuffs. Missing were dose–responseC – 100 
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ing coexposure to melamine and cyanuric acid.
Recently a NOAEL for crystal formation in rats exposed to
MEL + CYA for 7 days was established as 8.6 mg/kg bw/day (of
MEL and CYA each) (Jacob et al., 2011). Renal crystal formation
was a more sensitive indicator of effect as parameters such as renal
weight, blood urea nitrogen, creatinine and histopathologic lesions
were only evident in the 17.8 mg/kg bw rats. In the range ﬁnding
pig 7 day study, we noted signiﬁcant numbers of renal crystals in
the 2 pigs given the 10 mg/kg bw/day dosage. Thus, an adverse ef-
fect was noted at 10 mg/kg bw/day and therefore the 7 day NOAEL
based on crystal formation (based on 2 animals) was presumed to
be one dose level lower, 3.3 ml/kg bw/day. In the 28 day study, we
found crystals in one of the 8 pigs dosed at 3.3 mg/kg bw. Thus the
28 day NOAEL for male weanling pigs was established as 1.0 mg/
kg bw/day of MEL combined with 1.0 mg/kg bw/day of CYA.
A NOAEL can be deﬁned as ‘‘the highest exposure level at which
there are no biologically signiﬁcant increases in the frequency or
severity of adverse effect between the exposed population and its
appropriate control’’ (http://www.epa.gov/risk_assessment/glos-
sary.htm). There is, however, a general lack of consensus on the
deﬁnition of NOAEL (Dorato and Engelhardt, 2005) and it has been
pointed out that the NOAEL is a measured/estimated value and
may be different from the true no adverse effect level which lies
somewhere between the measured NOAEL and the measured low-
est observed adverse effect level (LOAEL). When trying to charac-
terize the risk for developing intratubular obstruction following
combined MEL and CYA ingestion, we need to consider the adverse
effect that is posed by only a few crystals vs. extensive crystal for-
mation throughout the kidney. At the moment, we do not know the
potential for several small foci of crystals to promote further intra-
renal crystallization of melamine–cyanurate crystals. Thus, when
faced with a low dose effect such as one cluster of crystals seen
in the one pig dosed at 3.3 mg/kg bw/day for 28 days (LOAEL),
we chose the conservative estimate for a NOAEL to be the next
lowest dose. This NOAEL must of course be considered within the
conﬁnes of this study and the fact that only 8 animals were exam-
ined at the 1 mg/kg bw/day dosage.
To further evaluate our ﬁndings we conducted bench mark dose
modelingwhich has been recommended as an alternative to NOAEL
(Filipsson et al., 2003; Kodell, 2009). BMD modeling was used by
WHO in 2008 to establish a tolerable daily intake (TDI) for mela-
mine and its analogs, however that modeling used a 14 day rat Na-
tional Toxicology Program (NTP) study in which onlymelamine had
been administered and the adverse effect measured was stone for-
mation. The BMDL10 for that 14 day study was 35 mg/kg bw/day.
Jacob et al., 2011, in a 7 day rat coexposure study, derived several
BMDL values, with kidney weights being the most sensitive of the
outcomes modeled (8.4–10.9 mg/kg bw/day depending on the
model used). The BMDLs of our pig coexposure studies were much
lower [1.49–1.52 mg/kg bw/day (7 day) and 1.89–2.03 mg/kg bw/
day (28 day)]. These values are intermediate between the NOAEL
and LOAEL that our 28 day study data indicated.
The NOAEL of 1 mg/kg bw/day derived from our 28 day study
corresponds to 25 mg/kg dry weight (25 ppm) in the feed of each
compound (conversion standards from IPCS, 1987). This level is
an order of magnitude higher than the 2.5 mg/kg dry weight
(ppm) ‘level of no concern’ in food other than infant formula, as
stated in the USFDA’s risk assessment for MEL alone (USFDA,
2008a,b). This NOAEL also supports the risk assessments of the
World Health Organization’s TDI, equivalent to 0.2 mg/kg bw/day
(approximately 8 ppm in food), and the European Food Safety
Authority’s TDI, also equivalent to 0.2 mg/kg bw/day (approxi-
mately 8 ppm in food), for melamine alone (conversion standards
from IPCS, 1987; WHO, 2008; EFSA, 2010). The United Nations’ Co-
dex Alimentarius has further set a maximum allowable amount ofmelamine alone in powdered infant formula at 1.0 mg/kg dry -
weight (1 ppm in formula; WHO, 2010). The USFDA has also stated
that in infant formula, 1.0 mg/kg dry weight (ppm) or below of
melamine or one of its analogs does not raise public health concern
(USFDA, 2008b).
Admittedly, the small number of animals used to determine this
NOAEL is a limitation. The sample numbers were chosen for prag-
matic reasons (number of physical conﬁnement pens, manpower,
logistics of dosing 20–50 kg animals daily, etc.) as well as a re-
sponse to IACUC requests to reduce the numbers of animals used
in research. Regardless, the samples are large enough to ﬁnd major,
if not minor, effects.
As Reimschuessel et al. (2008) found melamine–cyanurate crys-
tals to be stable in ethanol and to dissolve in formalin, ethanol was
used for tissue preservation in this study. However, consistent with
previous studies in ﬁsh and rats, the wet mount method was even
more sensitive in revealing crystals than histopathology of ethanol
ﬁxed or short-term formalin ﬁxed tissues, as crystals with a rank of
63 in wet mount failed to show en section (Reimschuessel et al.,
2008, 2010; Jacob et al., 2011).
It is important to realize other structures can appear in renal tu-
bules as seen in wet mount preparations. Investigators must be
familiar with both the appearance of melamine cyanurate crystals
as well as other crystalline and non-crystalline structures that can
be present in the kidneys of the experimental species, as well as
the other tissues or ﬂuids (i.e., urine) examined. (Fogazzi, 1996;
Fogazzi and Garigali, 2003).
The kidney function of the pigs in the higher dose groups of
MEL + CYA was compromised as evidenced by high BUN and CREA
levels. Pigs given 100 MEL + CYA and 33 MEL + CYA had BUN levels
of 58, 115, and 23 mg/dl and the 100 MEL + CYA pigs had CREA lev-
els of 7.7 and 8.9 mg/dl (Table 1). No comparisons were statistically
signiﬁcant because of the small sample sizes (n = 2). The elevated
levels of BUN and CREA in this study are consistent with previous
reports of melamine toxicity in pigs, rats and humans (Jenkins
et al., 1982; Kim et al., 2010; Shen et al., 2009; Sun et al., 2009).
Nilubol et al. (2009) found elevated levels of BUN (121.2 and
157.9 mg/dL) and CREA (11.9 and 15.0 mg/dL) in two dead weaned
pigs given feed contaminated with high levels of melamine, amm-
eline and cyanuric acid. In previous studies, rats given MEL-only
or CYA-only at the same high doses as those rats given MEL + CYA
did not have elevated BUN levels (Choi et al., 2010; Jacob et al.,
2011). Further, elevated BUN levels were not found in Holstein
cows given 50 g/cow MEL-only (approximately 83 mg/kg bw; Bat-
taglia et al., 2010). Data from the current study are consistent with
these ﬁndings. Data trends for CREA analyses were similar to those
of BUN when performed (Choi et al., 2010; Jacob et al., 2011). As
CREA is not dependant on serum nitrogen levels, it is unlikely that
the elevated BUN levels in the MEL + CYA pigs in the current study
were an artifact of high nitrogen content triazines in the serum but
instead due to poorly functioning kidneys.
Urine pH did not appear to affect crystal presence in the kidneys
of treated animals indicating that the range of 6.5–8 did not appear
to affect crystal solubility in the kidney as has been proposed
(Dominguez-Estevez et al., 2010). Urine pH in voided samples
may be different than the pH of the microenvironment in the kid-
ney when the crystals are formed.
Although originally unexpected, the presence of crystals in one
of the pigs given MEL-only is consistent with recent studies. Renal
crystals were found in 1 of 30 catﬁsh given only MEL and in 2 of 30
catﬁsh given only CYA (Reimschuessel et al., 2009). Crystals were
also found in renal wet mount analysis of 5 of 12 rats given
MEL-only (Jacob et al., 2011). Further, Puschner et al. (2010) found
CYA in the urine of cows given only MEL, and MEL in the urine of
cows given only CYA. The renal crystals in the MEL-only pig in this
study had morphology similar to the crystals in the MEL + CYA pigs
C.B. Stine et al. / Regulatory Toxicology and Pharmacology 60 (2011) 363–372 371but were more variable (Fig. 2). Some crystals from the MEL-only
pig had the typical radial appearance and were found in clumps,
however other crystals formed were tubular and found in branch-
ing agglomerations (Fig. 2 D, G and H). When these crystals were
characterized by UPLC-MS/MS, the transition ion ratios for the
MEL-only crystals, the MEL + CYA crystals and the standard were
within 30% of each other, indicating that the crystals from the
MEL-only pig were approximately 1:1 MEL and CYA. The difference
in ion ratios of the crystals from the pigs from the standard in solu-
tion may indicate the pig crystals contain other minor components
or biologic material. The ability of microorganisms to metabolize
triazines into a related compound is not unknown, speciﬁcally
MEL into CYA (Wackett et al., 2002; Seffernick et al., 2010). How-
ever, it is not currently known whether these or related microor-
ganisms reside and are biologically active in the gastrointestinal
tract of pigs, ﬁsh, rats or cows.
Further studies are needed to adequately evaluate the poten-
tial for exposure to very high dosages of MEL alone to cause pre-
cipitates within the kidney. There is one report of a basophilic
crystal in a human biopsy from an infant affected by the contam-
inated formula; however the composition of this crystal was not
determined (Sun et al., 2010). In addition, a re-evaluation of the
NTP histopathology results of the two-year carcinogenicity stud-
ies of MEL in F344 rats indicated that tubule dilatation and tubule
basophilia were salient features at the subchronic time-point and
that they had become ﬁbrotic by 2 years (Hard et al., 2009). The
authors speculated that the retrograde nephropathy observed
was due to MEL precipitation in the lower urinary tract creating
pressure through transient obstruction leading to the renal
changes. If formalin ﬁxation dissolved such crystals in the rat
study, human renal biopsies or necropsy specimens ﬁxed in for-
malin would also not show evidence of crystal nephropathy. It
is currently not known if such crystals would be precursors to
the melamine-uric acid stones found in the affected children in
2008.
Reviews of risk assessments stemming from the melamine con-
tamination incidents of 2007 and 2008 highlighted several areas
for further research (Hsieh et al., 2009; Bhat et al., 2010). Speciﬁ-
cally, data was needed to investigate the renal toxicity of melamine
and cyanuric acid combined because of the physical blockage of re-
nal tubules created by co-precipitation. In this study, we found a
level of melamine and cyanuric acid at which male weanling pigs
did not form renal crystals. The NOAEL is 1 mg/kg bw/day, which
corresponds to 25 mg/kg dry weight (ppm) in the feed. This data,
including a safety factor of 10, supports the levels of no concern
set in risk assessments prepared worldwide for human food as well
as for infant formula.Conﬂict of Interest
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